scholarly journals Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery

Author(s):  
Vimal K. Singh ◽  
Manisha Kalsan ◽  
Neeraj Kumar ◽  
Abhishek Saini ◽  
Ramesh Chandra
2016 ◽  
Vol 17 (2) ◽  
pp. 256 ◽  
Author(s):  
Mohammed Kawser Hossain ◽  
Ahmed Abdal Dayem ◽  
Jihae Han ◽  
Subbroto Kumar Saha ◽  
Gwang-Mo Yang ◽  
...  

2014 ◽  
Vol 9 (2) ◽  
pp. 73-81 ◽  
Author(s):  
Graham Walmsley ◽  
Jeong Hyun ◽  
Adrian McArdle ◽  
Kshemendra Senarath-Yapa ◽  
Michael Hu ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-24 ◽  
Author(s):  
Israa Ahmed Radwan ◽  
Dina Rady ◽  
Marwa M. S. Abbass ◽  
Sara El Moshy ◽  
Nermeen AbuBakr ◽  
...  

Cell-based therapies currently represent the state of art for tissue regenerative treatment approaches for various diseases and disorders. Induced pluripotent stem cells (iPSCs), reprogrammed from adult somatic cells, using vectors carrying definite transcription factors, have manifested a breakthrough in regenerative medicine, relying on their pluripotent nature and ease of generation in large amounts from various dental and nondental tissues. In addition to their potential applications in regenerative medicine and dentistry, iPSCs can also be used in disease modeling and drug testing for personalized medicine. The current review discusses various techniques for the production of iPSC-derived osteogenic and odontogenic progenitors, the therapeutic applications of iPSCs, and their regenerative potential in vivo and in vitro. Through the present review, we aim to explore the potential applications of iPSCs in dental and nondental tissue regeneration and to highlight different protocols used for the generation of different tissues and cell lines from iPSCs.


2020 ◽  
Author(s):  
Immacolata Belviso ◽  
Veronica Romano ◽  
Daria Nurzynska ◽  
Clotilde Castaldo ◽  
Franca Di Meglio

Induced Pluripotent Stem cells (iPSC) are adult somatic cells genetically reprogrammed to an embryonic stem cell-like state. Due to their autologous origin from adult somatic cells, iPSCs are considered a tremendously valuable tool for regenerative medicine, disease modeling, drug discovery and testing. iPSCs were first obtained by introducing specific transcription factors through retroviral transfection. However, cell reprogramming obtained by integrating methods prevent clinical application of iPSC because of potential risk for infection, teratomas and genomic instability. Therefore, several integration-free alternate methods have been developed and tested thus far to overcome safety issues. The present chapter provides an overview and a critical analysis of advantages and disadvantages of non-integrating methods used to generate iPSCs.


Sign in / Sign up

Export Citation Format

Share Document